Unternehmen
ONECHAIN IMMUNOTHERAPEUTICS S.L.
ONECHAIN IMMUNOTHERAPEUTICS S.L. – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Passend zu diesem Beitrag
Forschungsprojekte
- Contribution of Lipid Droplets to the pathogenesis and chemoresistance of Acute Myeloid Leukemia Acute Myeloid Leukemia (AML) results from the uncontrolled expansion of differentiation-defective hematopoiet… →
- Next generation, off-the-shelf, non fratricide-directed, CAR immunotherapy for relapse/refractory T-cell acute lymphoblastic leukemia R/R T-ALL remains a major clinical challenge. Despite improved survival rates thanks to intensive chemotherap… →
- Storming Immune Monogenic Conditions through Multiomic and Gene Editing Approaches The human immune system controls the efficiency to respond to infections and eliminate aberrant cells, such a… →
- Enabling the next generation in search of blood cancer cures The CarrerasPathfinder program is new a world-wide unique doctoral program that covers the entire spectrum of… →
- Development and characterization of a novel CAR T-cell therapy for NHL Non-Hodgkin lymphomas (NHL) are a group of blood cancers characterized by the expansion of malignant B lympho… →